Arthur C. Upton

1923-2015

Illustration from the National Cancer Institute, created by Betsy Upton

Arthur C. Upton (M.D. 1946, Residency 1949), most recently of Santa Fe, New Mexico, died Feb. 14 at the age of 92.

Upton was a celebrated pathologist and leader in the field of radiation science. He served as director of the National Cancer Institute, or NCI, and was also past president of the American Association for Cancer Research.

Upton was born Feb. 27, 1923, in Ann Arbor. When he was a child, his mother contracted pneumonia, an illness that was often fatal at the time. But under the care of a passionate family doctor, his mother recovered. It was then that Upton decided to become a physician.

At first, Upton wanted to pursue family medicine, but his interests shifted to laboratory research and pathology. He was compelled to understand disease at its most basic level. After completing his residency at U-M, he became a researcher at Oak Ridge National Laboratory. Later, he was the founding dean of the School of Basic Health Sciences at the State University of New York at Stony Brook, where he was also a member of the Department of Pathology.

Renowned in the field of radiation pathology, Upton was considered an expert on the effects of ionizing radiation.

In 1977, President Jimmy Carter appointed Upton as director of the NCI, a position he held until 1979. In this role, Upton oversaw research on cancer, its treatments and its causes. He provided guidance on many public health issues, including the Three Mile Island accident and radiation exposure in mammography.

"As a colleague and friend, Art taught me much about both decency and the politics of biomedical science," says Dan Fox, Ph.D., president emeritus of the Milbank Memorial Fund, the oldest endowed foundation in health care and public health in the nation, who worked with Upton at the Health Sciences Center. "I have never known anyone so loved."

Upton also served as president of the International Association for Radiation Research, the American Society for Experimental Pathology and the Radiation Research Society. He was an elected fellow of the Institute of Medicine and honorary life member of the New York Academy of Sciences.


More Articles About: Alumni Obituary Cancer (Oncology) Pathology
Featured News & Stories two men together walking outside
Health Lab
Exercise can reduce your cancer risk and help prevent its return
A director of exercise and health behavior in oncology shares ways to help cancer survivors live longer and better lives by incorporating exercise and other physical activity into everyday routines.
jama
Research News
Knowledge and Worry Following Review of Standard vs Patient-Centered Pathology Reports
The immediate release of test results to patients via patient portals is required.1,2 Unfortunately, pathology reports contain complex medical terminology, are not written for patients, and are often read by patients before discussion with their clinician.3,4 Whether patients can extract relevant diagnostic knowledge from such reports is unclear.
vial going into area full of vials with purple yellow and blue tops
Health Lab
First-of-its-kind blood test for head and neck cancer
A Michigan Medicine lab has begun providing a first-of-its-kind new cancer test. Developed at the University of Michigan, MyHPVscore is a highly accurate blood test that can detect HPV-related head and neck cancer by measuring fragments of tumor DNA in a patient’s bloodstream.
drawing of doctor with question mark about head with patient questioning and stressed over paperwork in exam room
Health Lab
People find medical test results hard to understand, increasing overall worry
In a published research letter in JAMA, researchers tested whether people could understand standard pathology reports and whether a patient-centered report might improve understanding.
drawing of three cells up against a wall behind glass, with two being blue and seeming innocent and the other green in the middle and angry, and scientists judging them and taking notes
Health Lab
Lighting up cancer cells with biolasers
University of Michigan researchers have developed a new way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.
PURPLE BLUE RED CELLS FLOATING
Health Lab
Using cellular therapy to treat cancer, and beyond
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.